Literature DB >> 25187230

miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.

Shi-huan Yu1, Chun-ling Zhang, Fu-shi Dong, Yi-mei Zhang.   

Abstract

MicroRNAs (miRNAs) play an important role in the development and progression of non-small cell lung cancer (NSCLC). Recently, several studies have shown that miR-99a is downregulated in various cancers, which can affect tumor initiation and maintenance. Herein, we found that miR-99a was downregulated in NSCLC tissues and suppressed tumor metastasis of NSCLC cells. Down-regulation of miR-99a is significantly associated with last-stage and tumor metastasis in NSCLC patients. Further functional experiments found that overexpression of miR-99a inhibit cell proliferation, migration, and invasion of NSCLC cells in vitro and tumor metastasis of NSCLC in vivo. In addition, we also found that AKT1 is directly involved in miR-99a-mediated tumor suppression. Restored the expression of AKT1 partially abolished the suppressive effects miR-99a on proliferation and invasion of NSCLC cells. Collectively, our data suggest that miR-99a plays an important role in the tumorigenesis and metastasis of NSCLC and may serve as a therapeutic target to avoid dissemination of NSCLC cells.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  AKT1; MATRIX METALLOPROTEINASE 2; NON-SMALL CELL LUNG CANCER; miR-99a; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25187230     DOI: 10.1002/jcb.24965

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  38 in total

1.  Expression patterns of the chromosome 21 MicroRNA cluster (miR-99a, miR-125b and let-7c) in chorioamniotic membranes.

Authors:  Bhavi P Modi; Sonya Washington; Scott W Walsh; Colleen Jackson-Cook; Kellie J Archer; Jerome F Strauss
Journal:  Placenta       Date:  2016-11-09       Impact factor: 3.481

2.  MiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression.

Authors:  Zhehui Liu; Ruiqin Wu; Guanzeng Li; Peng Sun; Qinghua Xu; Zhimin Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.

Authors:  Hong-Bo Zhang; Li-Chao Sun; Lan Ling; Lu-Hong Cong; Rui Lian
Journal:  Exp Ther Med       Date:  2016-07-27       Impact factor: 2.447

4.  A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down's syndrome (DS; trisomy 21).

Authors:  Yuhai Zhao; Vivian Jaber; Maire E Percy; Walter J Lukiw
Journal:  J Nat Sci       Date:  2017-09

5.  A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.

Authors:  Yunyun Li; Zhongzu Zhang; Xiaojing Zhang; Ying Lin; Tangshu Luo; Zhenghua Xiao; Qin Zhou
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 6.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

7.  miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.

Authors:  Yunchuan Sun; Jianyong Zhao; Xiaoming Yin; Xiangkun Yuan; Jianfei Guo; Jianqiang Bi
Journal:  Cell Prolif       Date:  2016-08-24       Impact factor: 6.831

8.  LncRNA LOXL1-AS1 promotes invasion and proliferation of non-small-cell lung cancer through targeting miR-324-3p.

Authors:  Ning Xie; Xiuqu Fei; Shuliang Liu; Jie Liao; Youjie Li
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

9.  Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.

Authors:  P N Alexandrov; M E Percy; Walter J Lukiw
Journal:  Cell Mol Neurobiol       Date:  2017-07-07       Impact factor: 5.046

10.  miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1.

Authors:  Yushun Gao; Qi Xue; Dali Wang; Minjun Du; Yanjiao Zhang; Shugeng Gao
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.